Holen Sie sich die Stockscreener-App
16.67
1.59%
-0.27
Handel nachbörslich:
16.72
0.05
+0.30%
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Analyzing recovery setups for Innoviva Inc. investors2025 Sector Review & Stock Portfolio Risk Control - newser.com
Innoviva stock hits 52-week low at 16.66 USD By Investing.com - Investing.com Australia
How strong is Innoviva Inc. stock revenue growthJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com
What candlestick patterns are forming on Innoviva Inc.Market Movement Recap & Consistent Profit Trading Strategies - newser.com
Innoviva, Inc. $INVA Shares Sold by KLP Kapitalforvaltning AS - Defense World
What Fibonacci levels say about Innoviva Inc. rebound2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
What sentiment indicators say about Innoviva Inc. stockJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Heatmap analysis for Innoviva Inc. and competitorsEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Innoviva (NASDAQ:INVA) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Technical analysis overview for Innoviva Inc. stockVolume Spike & Comprehensive Market Scan Insights - newser.com
Why Innoviva Inc. (HVE) stock appeals to dividend investors2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
New Strong Buy Stocks for October 10th - sharewise.com
Full technical analysis of Innoviva Inc. stock2025 Short Interest & Accurate Buy Signal Notifications - newser.com
What drives Innoviva Inc stock priceMoving Average Crossovers & Build a Smarter Portfolio Right Now - earlytimes.in
Weiss Ratings Reaffirms "Hold (C)" Rating for Innoviva (NASDAQ:INVA) - MarketBeat
QRG Capital Management Inc. Has $2.26 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025 - BioSpace
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critic - PharmiWeb.com
Is Innoviva, Inc.'s (NASDAQ:INVA) Recent Price Movement Underpinned By Its Weak Fundamentals? - 富途牛牛
Are Investors Undervaluing Innoviva (INVA) Right Now? - sharewise.com
Using Bollinger Bands to evaluate Innoviva Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com
Is now a turning point for Innoviva Inc.July 2025 Highlights & Smart Swing Trading Alerts - newser.com
Why Innoviva Inc. stock appeals to dividend seekersJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Innoviva Inc.Global Markets & Reliable Intraday Trade Plans - newser.com
How to interpret RSI for Innoviva Inc. stock2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Will earnings trigger a reversal in Innoviva Inc.Weekly Risk Summary & Weekly Momentum Picks - newser.com
Is this a good reentry point in Innoviva Inc.Insider Selling & Verified Swing Trading Watchlist - newser.com
Innoviva (NASDAQ:INVA) Stock Rating Lowered by Wall Street Zen - Defense World
Innoviva (NASDAQ:INVA) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Brokerages Set Innoviva, Inc. (NASDAQ:INVA) PT at $37.60 - Defense World
Order flow analysis tools used on Innoviva Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Innoviva (NASDAQ:INVA) Research Coverage Started at The Goldman Sachs Group - Defense World
Is Innoviva Inc. showing signs of accumulationQuarterly Profit Review & Community Driven Trade Alerts - newser.com
What Does Technical Analysis Say About Star Delta Transformers Limited StockInflation Impact on Stocks & Market Volatility Strategies - earlytimes.in
Innoviva (NASDAQ:INVA) Coverage Initiated at The Goldman Sachs Group - MarketBeat
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):